Workflow
SNIBE(300832)
icon
Search documents
新产业:产品获得医疗器械注册证
人民财讯12月9日电,新产业(300832)12月9日公告,公司近日收到了广东省药品监督管理局颁发的1 项医疗器械注册证,产品为血管紧张素Ⅰ测定试剂盒(磁微粒化学发光法),用于体外定量测定人血浆 中血管紧张素Ⅰ(Angiotensin Ⅰ)的含量。临床上用于心血管功能的辅助评价。 ...
新产业(300832) - 关于获得医疗器械注册证的公告
2025-12-09 09:26
证券代码:300832 证券简称:新产业 公告编号:2025-093 深圳市新产业生物医学工程股份有限公司 1 此次公司在国内取得《医疗器械注册证》的产品血管紧张素Ⅰ测定试剂盒(磁 微粒化学发光法)创新性使用了能够识别抗原抗体复合物的抗体作为检测抗体, 通过夹心法对血管紧张素Ⅰ进行检测,进一步提高了试剂的灵敏度、精密度和特 异性等性能,进一步提升公司高血压检测方面的市场竞争力。 关于获得医疗器械注册证的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 近日,深圳市新产业生物医学工程股份有限公司(以下简称"公司")收到 了广东省药品监督管理局颁发的 1 项《医疗器械注册证》。具体情况如下: | 产品名称 | 注册 分类 | 注册证编号 | | | 注册证有效期 | | | 适用范围 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 血管紧张素Ⅰ测 | | 粤械注准 | 2025 | 年 12 | 月 | 05 | 日至 | 本试剂盒用于体外定量测 定人血浆中血管紧张素Ⅰ | | 定试剂盒( ...
龙华百亿级战新产业基金集群落地,AIC基金“官宣即运作”
Nan Fang Du Shi Bao· 2025-12-09 09:25
12月9日,龙华区在国际合作中心召开产融结合高质量发展大会,集中发布一批标志性金融合作成果。 会上,百亿级战新产业基金集群正式落地,其中深资本建信龙华AIC基金、深担农银龙华AIC基金两支 总规模均为20亿元的AIC基金备受瞩目,标志着龙华在深化产融结合、赋能实体经济方面迈出关键一 步。 作为深圳制造业大区,龙华工业占GDP比重超四成,推动金融与产业深度融合、服务实体经济高质量发 展,已成为区域发展的核心战略。据龙华区发展和改革局相关负责人介绍,本次大会龙华区官宣落地百 亿级战新产业基金集群,其中尤为引人瞩目的是深资本建信龙华AIC基金、深担农银龙华AIC基金,两 支基金总规模均为20亿元,重点布局深圳市"20+8"产业集群和龙华区"1+2+3"产业体系中的数字经济、 新能源、高端医疗器械、集成电路、人工智能等赛道。 值得关注的是,深担农银龙华AIC基金在大会现场即完成首批意向投资项目签约,实现"官宣即运作"的 高效落地。首批签约企业包括昂湃技术、圭华智能、精泰达等多家辖区优质拟上市企业,它们分别聚焦 于液冷散热、精密激光装备、自动化测试设备等高端制造赛道。 "我们看好深圳和龙华制造业良好基础,利用龙华区'一 ...
挑战与机遇并存,看这座省级新区如何发力
Qi Lu Wan Bao· 2025-12-09 02:20
2022年12月9日,德州天衢新区正式揭牌成立。如今,走过了整整三年的时间,作为省委、省政府擘画的四大省级新区之一,正值德州打造对接京津冀桥 头堡、引领中心城区东移、建设新增长极的重大机遇。 三年来,德州天衢新区先行先试、敢闯敢试,改革步履不停,一个个项目向前奔跑,一座座厂房拔地而起,一个个产业飞跃而升,势头强劲,生机蓬勃, 成为这里新的注脚。 产业集聚:新质生产力撑起发展脊梁 集成电路产业从"一粒芯"到"百亿链"的突破,是新区产业变革的生动诠释。如今这里已集聚多家半导体企业,形成从衬底外延到终端应用的完整产业链, 2025年1—9月新一代信息技术产业营收达107.1亿元,同比增长31.69%。有研集团7个项目落地投产,威讯半导体二期扩产打造百亿级封装基地,先导科技 激光雷达项目3个月实现"签约即开工",刷新产业(300832)落地速度。 "供应链+园区"模式更让产业集群效应凸显。AI智能安防产业园半年引来7家上下游企业,沃良智能"2月入驻4月投产",凭借园区供应链金融支持,7个月 销售额突破1400万元,实现"上下楼就是上下游"的集聚优势。食品制造、高端装备等六大主导产业齐头并进,2025年一季度32.2亿 ...
深圳龙岗产业园区:搭建工业框架,聚焦高新产业,多元格局成型!
Core Insights - The development of Longgang Industrial Park in Shenzhen represents a transformation from low-end processing trade to a world-class industrial hub, showcasing its evolution into a diverse and high-end industrial cluster [1] Phase Summaries Initial Phase (1993 - 2000) - Longgang began its industrial journey by establishing early industrial parks to attract foreign investment, leading to the establishment of over 3,700 processing trade enterprises by 1997 [1] - The arrival of major companies like Huawei and BYD in 1998 marked a pivotal moment, laying the groundwork for future high-end industrial transformation [1] Upgrade Phase (2001 - 2017) - The focus shifted towards private and high-tech industries, with policies supporting private enterprises and the establishment of a robust electronic information industry [1] - The transformation of old industrial parks began, with significant developments like the Dawan Software Town and the integration of cultural and technological industries [1] Gathering Phase (2018 - 2021) - Longgang ranked first in the national industrial top 100 for the first time in 2018, maintaining this position for seven consecutive years [2] - The establishment of a digital creative industry corridor and the construction of the Huawei Industrial Internet Innovation Center were key initiatives during this period [2] High-Quality Phase (2022 - Present) - Longgang has developed a diverse industrial structure characterized by a "3 + 4" model, enhancing its role in empowering emerging industries [3] - The AI and robotics sectors have become core pillars, with over 350 companies in the AI industry chain and significant government support [4] - The semiconductor industry is also expanding, with a planned 138-hectare semiconductor industrial cluster expected to host 215 companies by mid-2025 [4] Emerging Sectors - The low-altitude economy is gaining momentum, with the establishment of the "Aerial High De" headquarters and the entry of multiple companies into the sector [5] - Traditional industries like eyewear are transforming through park empowerment, integrating fashion design elements [5] Spatial Expansion and Infrastructure - Longgang is continuously optimizing its industrial space, with significant projects like the second phase of the AI Town and the semiconductor industrial cluster providing high-quality office and production spaces [6] - The overall rental rate of the industrial parks remains above 70%, indicating strong demand [6] Investment and Business Development - In 2024, Longgang attracted 130 new enterprises, with a total new rental area of 127,500 square meters [7] - The establishment of a "Small and Medium Enterprises Overseas Reception Hall" in Fenglong Technology Park highlights the region's commitment to fostering international business collaboration [7] Ecosystem and Support Services - Longgang is enhancing its industrial ecosystem through various policies and services, including a three-year action plan for AI and a commitment of 10 billion yuan for AI product applications [8] - The establishment of partnerships between universities and enterprises is accelerating the commercialization of technological innovations [8]
魏桥系“站台”,山东铝业大亨崔立新产业版图再扩展
Da Zhong Ri Bao· 2025-12-05 05:55
Core Viewpoint - The Hong Kong stock market recently witnessed the largest IPO in the industrial metals sector in three years, with Innovation Industry Group Co., Ltd. (02788.HK) officially listing on the Hong Kong Stock Exchange, led by Shandong aluminum tycoon Cui Lixin [2][3] Group 1: IPO Details - Innovation Industry's IPO is among the top ten largest in Hong Kong this year and the largest in the industrial metals sector since 2022 [3] - The cornerstone investor list includes China Hongqiao Group, which subscribed for $30 million, signaling strong regional industrial collaboration [3][21] - The IPO attracted 17 cornerstone investors, raising approximately $351 million [21] Group 2: Company Background - Cui Lixin, a 56-year-old entrepreneur, is the chairman of Shandong Innovation Group and the actual controller of the A-share listed company Innovation New Materials [5][6] - Shandong Innovation Group employs over 20,000 people and ranked 330th in the 2024 China Top 500 Enterprises, with annual sales exceeding 120 billion yuan [7] Group 3: Business Operations - Innovation Industry focuses on the upstream aluminum industry chain, including alumina refining and electrolytic aluminum smelting, with operations in Hohhot, Inner Mongolia, and Binzhou, Shandong [10][11] - The electrolytic aluminum smelting plant in Hohhot is projected to be the fourth largest in North China by 2024, while the alumina refining plant in Binzhou benefits from strategic logistics advantages [11][14] Group 4: Financial Performance - Innovation Industry's revenue increased from 13.49 billion yuan in 2022 to 15.16 billion yuan in 2024, with net profit rising from 913 million yuan to 2.63 billion yuan [15] Group 5: Client Relationships - Innovation New Materials, controlled by Cui Lixin, is the largest customer of Innovation Industry, accounting for 78.8% and 76.6% of total revenue in 2023 and 2024, respectively [16][17] - The strategic proximity of Innovation New Materials' new production base to Innovation Industry's facilities enhances operational efficiency [18][20] Group 6: Industry Collaboration - The collaboration between local aluminum industry giants, such as Innovation Industry and China Hongqiao, highlights the synergy within the regional aluminum supply chain [21][22] - The listing marks a new phase for Shandong Innovation Group, transitioning to a dual-platform strategy with both A-share and H-share listings [22]
上交所:郑州高新产业投资集团有限公司债券12月8日挂牌,代码280880
Sou Hu Cai Jing· 2025-12-05 04:45
依据《上海证券交易所非公开发行公司债券挂牌规则》等规定,上交所同意郑州高新产业投资集团有限 公司2025年面向专业投资者非公开发行科技创新公司债券(第一期)于2025年12月8日起在上交所挂 牌,并采取点击成交、询价成交、竞买成交、协商成交交易方式。该债券证券简称为"25郑产K1",证 券代码为"280880"。 12月5日,上交所发布关于郑州高新产业投资集团有限公司2025年面向专业投资者非公开发行科技创新 公司债券(第一期)挂牌的公告。 来源:市场资讯 ...
江苏设区市一批法规开全国先河
Xin Hua Ri Bao· 2025-12-04 22:40
Group 1 - The legislative reform in Jiangsu has led to the establishment and modification of 504 local regulations over the past decade, reflecting national strategies and local needs [1] - The local legislative power granted to cities has enabled innovative and exploratory legislation, particularly in new industries and business models [1] - The implementation of the "Jiangsu Province Production and Operation Units Safety Risk Management Regulations" marks the first local legislation focused on safety risk management in the country, enhancing safety risk reporting and management [2] Group 2 - The "Jiangsu Province Medical Security Regulations" introduced in 2023 is the first comprehensive local legislation on medical security at the provincial level, aiming for full coverage of long-term care insurance by the end of 2024 [2] - Nanjing has enacted over 50 local regulations in the past decade, significantly improving its legal governance index, with notable legislation like the "Nanjing National Memorial Day Protection Regulations" [3] - Collaborative legislative efforts among cities in the Huaihai Economic Zone have addressed common regional issues, leading to effective environmental protection regulations [4]
三友集团:战新产业占比将达70%以上
Core Viewpoint - Tangshan Sanyou Group is implementing a "three-turn" strategy focusing on transitioning to marine industries, green transformation, and high-quality development, aiming to evolve from a traditional chemical enterprise to a high-tech company [1] Group 1: Strategic Initiatives - The company has invested nearly 4 billion yuan in R&D since 2022, with an R&D intensity of 5.7% [1] - Sanyou Group is executing three major projects in high-end electronic chemicals, establishing six new companies under the Blue Ocean Technology initiative, with an expected new industry contribution of over 70% upon full production [1] Group 2: Key Projects - The high-end electronic chemicals project aims to address import bottlenecks and achieve domestic substitution [1] - The sodium battery project has established the first large-scale battery-grade sodium carbonate production line in China and the world's first industrial application of sodium energy storage equipment [1] - The concentrated seawater resource utilization project has pioneered efficient utilization technology for concentrated seawater, addressing global challenges in waste treatment after seawater desalination [1] Group 3: Product Innovation - The company is focusing on product innovation to capture high-end markets, developing over 40 high-value, high-tech products including silicon-based, magnesium-based, bromine series, and chlorine series [1] - 15 technical products, including sustainable viscose short fibers, have reached advanced levels both domestically and internationally, with new product output accounting for over 30% and high-end product output for over 45% [1]
12月3日医疗健康R(480016)指数跌0.42%,成份股人福医药(600079)领跌
Sou Hu Cai Jing· 2025-12-03 10:05
Core Points - The Medical Health R Index (480016) closed at 7284.72 points, down 0.42%, with a trading volume of 17.046 billion yuan and a turnover rate of 0.61% [1] - Among the index constituents, 23 stocks rose while 26 fell, with TeBao Bio leading the gainers at 2.85% and Renfu Pharmaceutical leading the decliners at 3.33% [1] Index Constituents Summary - The top ten constituents of the Medical Health R Index include: - WuXi AppTec (sh603259) with a weight of 13.66%, latest price at 87.62, down 2.01%, and a market cap of 261.437 billion yuan [1] - Hengrui Medicine (sh600276) with a weight of 11.00%, latest price at 60.97, down 0.25%, and a market cap of 404.670 billion yuan [1] - Mindray Medical (sz300760) with a weight of 7.57%, latest price at 199.50, down 0.56%, and a market cap of 241.882 billion yuan [1] - United Imaging Healthcare (sh688271) with a weight of 4.27%, latest price at 128.88, up 0.13%, and a market cap of 106.217 billion yuan [1] - Pianzai Shou (sh600436) with a weight of 3.48%, latest price at 171.48, up 1.33%, and a market cap of 103.457 billion yuan [1] - Aier Eye Hospital (sz300015) with a weight of 3.42%, latest price at 11.35, down 1.30%, and a market cap of 105.843 billion yuan [1] - Kelun Pharmaceutical (sz002422) with a weight of 2.59%, latest price at 34.00, down 0.03%, and a market cap of 54.334 billion yuan [1] - Xinhecheng (sz002001) with a weight of 2.42%, latest price at 24.44, up 0.20%, and a market cap of 75.114 billion yuan [1] - Fosun Pharma (sh600196) with a weight of 2.39%, latest price at 27.05, down 0.15%, and a market cap of 72.235 billion yuan [1] - Ziji Shenzhou (sh688235) with a weight of 2.27%, latest price at 275.20, down 1.59%, and a market cap of 423.995 billion yuan [1] Capital Flow Analysis - The Medical Health R Index constituents experienced a net outflow of 1.159 billion yuan from institutional investors, while retail investors saw a net inflow of 999 million yuan [1] - Detailed capital flow for specific stocks shows: - Health元 (600380) had a net inflow of 34.2431 million yuan from institutional investors [2] - Hengrui Medicine (600276) had a net inflow of 29.9909 million yuan from institutional investors [2] - Long Spring High-tech (000661) had a net inflow of 19.8154 million yuan from institutional investors [2] - The index constituents underwent adjustments, adding four new stocks and removing one [2]